title: Acidic FGF regulation of hyperproliferation of fibroblasts in human autosomal dominant polycystic kidney disease.
abstract: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by cystic tubule enlargement and expansion of the interstitium associated with fibrosis. Our previous studies have analyzed the increased proliferation of cystic epithelial cells and this study examines the basis of increased proliferation of interstitial fibroblasts associated with ADPKD disease progression. ADPKD fibroblasts show phenotypic alterations in vitro, have acquired the capacity to grow in soft agar, and show an increased mitogenic response to a variety of growth factors particularly acidic FGF (aFGF). ELISA, Western immunoblot analysis, and immunocytochemistry showed increased aFGF content in ADPKD tissues and fibroblasts in culture, and aFGF was secreted into the extracellular matrix and conditioned medium, respectively. No alterations in aFGF receptor number were found, but Scatchard analysis of 125I-aFGF binding suggested an increased affinity of binding to the low affinity receptor, and covalent cross-linking analysis suggested the presence of novel putative receptors (120 kDa) in ADPKD fibroblasts. Signaling abnormalities were found, since aFGF incubation resulted in the tyrosine phosphorylation of additional substrates, more rapidly and for a more sustained duration in ADPKD fibroblasts than in normal fibroblasts. These findings suggest an important role for acidic FGF in the hyperproliferation of interstitial fibroblasts associated with disease progression in human ADPKD.
authors.affiliation: Department of Physiology, UMDNJ-RWJ (formerly Rutgers) Medical School, Piscataway 08854, USA.
authors.forename: N T
authors.initials: NT
authors.lastname: Kuo
authors.forename: J T
authors.initials: JT
authors.lastname: Norman
authors.forename: P D
authors.initials: PD
authors.lastname: Wilson
mesh_terms: D016022:Case-Control Studies; D002455:Cell Division / Q000502:physiology; D002478:Cells, Cultured; D018450:Disease Progression; D016220:Fibroblast Growth Factor 1 / Q000502:physiology*; D005347:Fibroblasts / Q000166:cytology; D006133:Growth Substances / Q000502:physiology; D006801:Humans; D008934:Mitogens / Q000502:physiology*; D010960:Plasminogen Activators / Q000502:physiology; D016891:Polycystic Kidney, Autosomal Dominant / Q000473:pathology / Q000503:physiopathology*; D017468:Receptors, Fibroblast Growth Factor / Q000502:physiology; D015398:Signal Transduction / Q000502:physiology; D014568:Urokinase-Type Plasminogen Activator / Q000502:physiology
chemical_list: D006133:Growth Substances; D008934:Mitogens; D017468:Receptors, Fibroblast Growth Factor; D016220:Fibroblast Growth Factor 1; D010960:Plasminogen Activators; D014568:Urokinase-Type Plasminogen Activator